NCT00210431已完成不适用
A Post Marketing Surveillance Study of Dysport Formulated With a Batch of Bulk Active Substance From a New Primary Manufacturing Facility at the Centre for Applied Microbiology & Research (CAMR)
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Ipsen
- 入组人数
- 783
- 试验地点
- 35
- 主要终点
- - assessment of efficacy as assessed by treating physician at scheduled follow up visit
研究概览
简要总结
The purpose of this study is to provide further information regarding the risks and benefits of Dysport in marketed indications.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Prospective
入排标准
- 年龄范围
- 2 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •adult or child over the age of 2 years
- •scheduled to receive Dysport as per their normal treatment practice, and in conformance with their country's Summary of Product Characteristics
排除标准
- •history of hypersensitivity to Dysport or drugs with a similar chemical structure
- •treatment with any other investigational drug within the last 30 days before survey entry
结局指标
主要结局
- assessment of efficacy as assessed by treating physician at scheduled follow up visit
- data on adverse events since treatment with Dysport
次要结局
未报告次要终点
研究者
研究点 (35)
Loading locations...
相似试验
已完成
不适用
Post Marketing Surveillance Study for ADYNOVATE in South KoreaHemophilia ANCT03824522Takeda341
已完成
不适用
Evaluate the Safety and Effectiveness of Sovaldi in Participants With Chronic Hepatitis C Virus (HCV) Infection in KoreaHepatitis C VirusNCT02907996Gilead Sciences2,033
已完成
不适用
A Study for PMS of AZL-M/CLD FDC in the Treatment of Participants With Essential HTN in South KoreaEssential HypertensionNCT04470830Celltrion Pharm, Inc.718
已完成
4 期
Safety of Haemophilus Influenza Type b Vaccine When Administered to Korean ChildrenHaemophilus Influenzae Type B InfectionNCT01404962Novartis Vaccines764
已完成
不适用
Regulatory Post Marketing Surveillance Study on Nexavar®Carcinoma, HepatocellularCarcinoma, Renal CellNCT01012011Bayer2,845